 Genet 1997;34:767-771) 
In 1969, Boucher and Gibberd' described two sisters with "a combination of several features which although frequently occurring alone or in pairs, rarely occur all in one patient". The features referred to are chorioretinal degeneration, hypogonadism, and ataxia, which at that time did not "conform to any of the recognised syndromes".
Six years later, Neuhauser and Opitz2 described a new autosomal recessive syndrome combining hypogonadotrophic hypogonadism and cerebellar ataxia. Although ophthalmological examination of two patients described in this study showed retinal pigmentary changes and atrophy, these findings were not considered to be part of the syndrome. The similarities between the cases reported by them and those reported by Boucher and Gibberd' were therefore not recognised until 1989 when Limber et al,3 on re-evaluation of one of the patients described by Neuhauser and Opitz,2 suggested that this was a specific pleiotropic single gene disorder and named it Boucher-Neuhauser syndrome.
So far, 17 cases from nine families have been reported, only three of these families in genetic publications.>' In the present study, we describe two additional cases and after reviewing the published reports list the main clinical characteristics of this rare syndrome and its differential diagnosis.
Case reports CASE 1 The proband, a 31 year old male, was born after a normal pregnancy and delivery. He was seen by an ophthalmologist at the age of 23 years because of slowly progressive visual problems consisting of night blindness and constricting visual fields. His visual acuity was 5/10 in both eyes. Intraocular pressure was 17 mmHg on the right and 18 mmHg on the left. Fundoscopy showed bilateral atrophy of the retinal pigment epithelium and choriocapillaris in the mid peripheral areas, with peripapillary atrophy and retinal pigment epithelium alterations of the maculae. The electro-oculogram was disturbed bilaterally while electroretinography showed no photopic or scotopic responses at all. A fluorescein angiogram indicated central choriocapillaris atrophy. Colour discrimination was not disturbed. The diagnosis of choroideremia was suggested.
At 25 years of age, he was examined because of poor sexual development. He never needed to shave and although he had erections on awakening no ejaculation occurred. His height was 178 cm (25th centile) and weight 65 kg (25th centile). Compared to his trunk, he had relatively long limbs. There was sparse pubic and normal axillary hair with absent chest and facial hair. There was no gynaecomastia and he had a normal masculine voice. He had a very small scrotum and his penis and testicles were small but without anatomical abnormalities. Laboratory tests, including a complete blood count, routine blood chemistry profile, and urine analysis, were within normal limits. Endocrinological studies disclosed hypogonadotrophic hypogonadism. The serum level of testosterone was extremely low (0.86 nmol/l, normal 10-35) and the concentrations of luteinising hormone (LH) and follicle stimulating hormone (FSH) were below the lowest detectable level (<1.0 mIU/ml). There was no response to a single intravenous dose of LH releasing hormone (LH-RH) even after repeated stimulation with LH-RH for one week, suggesting an abnormal pituitary function. The serum levels of oestradiol, cortisol, prolactin, thyroid stimulating hormone (TSH), and thyroxine (T4) were, however, all normal. Bone age, determined according to Greulich Besides retinitis pigmentosa other diagnoses like (early) senile macular degeneration,-retinal chorioretinitis,2 and choroideremia (present study) have been suggested. In addition, it seems that independent of the severity of the observed chorioretinal degeneration, the visual outcome varies between almost no loss of vision and complete blindness. This illustrates the variable presentation of the ophthalmological manifestations in Boucher-Neuhauser syndrome.
In addition to the more common neurological findings in Boucher-Neuhauser syndrome (table  2) , dysmetria,>467 dysdiadochokinesis,2 7 
